CD4 and cancer: Szajnik et al. reported TEXs separated from serum and ascites of cancer patients can phosphorylate Smad2/3 and Stat3, inducing CD4+CD25− T cell transformed into CD4+CD25+Foxp3+ Treg cell [6, 73].